Efficacy and safety of Shen-Song-Yang-Xin capsule for treating arrhythmia in the elderly patients with coronary heart disease: Protocol for a systematic review and meta-analysis

BACKGROUND: Coronary heart disease (CHD) is a major cause of mortality worldwide. Shen-Song-Yang-Xin capsule (SSYXC) has received extensive attention as an alternative therapy in improving myocardial ischemia and hypoxia effectively. In addition, there has been no systematic review or meta-analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Zhicong, Zhuang, ZhenJie, He, YingXian, Yang, ZhaoJun, Song, Yinzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320059/
https://www.ncbi.nlm.nih.gov/pubmed/30572466
http://dx.doi.org/10.1097/MD.0000000000013599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320059/
https://www.ncbi.nlm.nih.gov/pubmed/30572466
http://dx.doi.org/10.1097/MD.0000000000013599

Ejemplares similares